Colchicine Safety in Patients with Hypertension for Gout Flare Management

First-line Treatment Options for Gout Flares

Colchicine is a recommended first-line treatment for acute gout flares, particularly when administered within 12 hours of symptom onset, according to the European League Against Rheumatism 1, 2
The recommended dosing regimen is a loading dose of 1 mg followed 1 hour later by 0.5 mg on day 1, as suggested by the American College of Rheumatology 3, 4

Hypertension is a common comorbidity in gout patients and should be screened for and managed as part of comprehensive gout care, according to the European Society of Cardiology 5, 6
Unlike NSAIDs, which can worsen hypertension and are contraindicated in many cardiovascular conditions, colchicine does not adversely affect blood pressure control, as stated by the European Heart Journal 7

Colchicine should be avoided in patients with severe renal impairment (GFR <30 mL/min), as recommended by the National Kidney Foundation 3, 8
Colchicine should not be given to patients receiving strong P-glycoprotein and/or CYP3A4 inhibitors such as cyclosporin or clarithromycin due to risk of serious toxicity, according to the European Medicines Agency 3
If the patient is on statins, be aware of potential neurotoxicity and/or muscular toxicity with colchicine, as warned by the American College of Cardiology 2

If colchicine cannot be used, oral corticosteroids (30-35 mg/day of prednisolone for 3-5 days) are an effective alternative, as suggested by the British Society for Rheumatology 3, 4
Intra-articular corticosteroid injection is another option for monoarticular gout, according to the European League Against Rheumatism 7
IL-1 inhibitors may be considered in patients with frequent flares who have contraindications to colchicine, NSAIDs, and corticosteroids, as recommended by the American College of Rheumatology 5

Treat gout flares as early as possible - the "pill in the pocket" approach is recommended for fully informed patients, according to the European League Against Rheumatism 9, 10
Address underlying hypertension and other cardiovascular risk factors as part of comprehensive gout management, as suggested by the European Society of Cardiology 5, 6
Consider prophylactic colchicine (0.5-1 mg/day) during the first 6 months of urate-lowering therapy to prevent flares, as recommended by the American College of Rheumatology 2
Initiate urate-lowering therapy in patients with hypertension and gout to achieve serum urate levels <6 mg/dL (360 mmol/L), according to the European League Against Rheumatism 6

For acute gout flares in patients with CKD, intra-articular or oral glucocorticoids may be safer alternatives if colchicine is contraindicated or poorly tolerated, as recommended by the American Journal of Kidney Diseases and Arthritis Care & Research 11, 12
Low-dose oral corticosteroids (e.g., prednisone) can be effective for acute flare management with potentially fewer renal concerns, according to Arthritis Care & Research 12